These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28331292)

  • 21. Effects of felbamate on the pharmacokinetics of a low-dose combination oral contraceptive.
    Saano V; Glue P; Banfield CR; Reidenberg P; Colucci RD; Meehan JW; Haring P; Radwanski E; Nomeir A; Lin CC
    Clin Pharmacol Ther; 1995 Nov; 58(5):523-31. PubMed ID: 7586946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double-layer weekly sustained release transdermal patch containing gestodene and ethinylestradiol.
    Gao Y; Liang J; Liu J; Xiao Y
    Int J Pharm; 2009 Jul; 377(1-2):128-34. PubMed ID: 19463930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined ethinylestradiol/gestodene contraceptive patch: two-center, open-label study of ovulation inhibition, acceptability and safety over two cycles in female volunteers.
    Heger-Mahn D; Warlimont C; Faustmann T; Gerlinger C; Klipping C
    Eur J Contracept Reprod Health Care; 2004 Sep; 9(3):173-81. PubMed ID: 15697107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and serum protein binding of gestodene and 3-keto-desogestrel in women after single oral administration of two different contraceptive formulations.
    Kuhnz W; Schütt B; Power J; Back DJ
    Arzneimittelforschung; 1992 Sep; 42(9):1139-41. PubMed ID: 1445482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and tolerability of a new low-dose contraceptive patch in obese and nonobese women.
    Kaunitz AM; Archer DF; Mishell DR; Foegh M
    Am J Obstet Gynecol; 2015 Mar; 212(3):318.e1-8. PubMed ID: 25220709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transdermal ethinylestradiol/norelgestromin: a review of its use in hormonal contraception.
    Goa KL; Warner GT; Easthope SE
    Treat Endocrinol; 2003; 2(3):191-206. PubMed ID: 15966567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of steady-state ambrisentan on the pharmacokinetics of a single dose of the oral contraceptive norethindrone (norethisterone) 1 mg/ethinylestradiol 35 microg in healthy subjects: an open-label, single-sequence, single-centre study.
    Spence R; Mandagere A; Walker G; Dufton C; Boinpally R
    Clin Drug Investig; 2010; 30(5):313-24. PubMed ID: 20384387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Simultaneous determination of gestodene, etonogestrel and ethinylestradiol in plasma by LC-MS/MS following derivatization].
    Liu XF; Ding CG; Ge QH; Zhou Z; Zhi XJ
    Yao Xue Xue Bao; 2010 Jan; 45(1):87-92. PubMed ID: 21351455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transdermal contraception methods: today's patches and new options on the horizon.
    Nelson AL
    Expert Opin Pharmacother; 2015 Apr; 16(6):863-73. PubMed ID: 25800084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results.
    Kirkman RJ; Bromham DR; O'Connor TP; Sahota JE
    Br J Fam Plann; 1999 Jul; 25(2):36-40. PubMed ID: 10454652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transdermal contraception.
    Creasy GW; Abrams LS; Fisher AC
    Semin Reprod Med; 2001 Dec; 19(4):373-80. PubMed ID: 11727179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of mavoglurant (AFQ056), a selective mGluR5 antagonist, on the pharmacokinetics of a combined oral contraceptive containing ethinyl estradiol and levonorgestrel in healthy women.
    Sivasubramanian R; Chakraborty A; Rouzade-Dominguez ML; Neelakantham S; Jakab A; Mensinga T; Legangneux E; Woessner R; Ufer M
    Int J Clin Pharmacol Ther; 2015 Jul; 53(7):550-6. PubMed ID: 25943176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ethinyl estradiol and levonorgestrel pharmacokinetics with a low-dose transdermal contraceptive delivery system, AG200-15: a randomized controlled trial.
    Archer DF; Stanczyk FZ; Rubin A; Foegh M
    Contraception; 2012 Jun; 85(6):595-601. PubMed ID: 22133660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A pharmacokinetic study with a low-dose oral contraceptive containing 20 microg ethinylestradiol plus 100 microg levonorgestrel.
    Endrikat J; Blode H; Gerlinger C; Rosenbaum P; Kuhnz W
    Eur J Contracept Reprod Health Care; 2002 Jun; 7(2):79-90. PubMed ID: 12201326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of etonogestrel and ethinylestradiol released from a combined contraceptive vaginal ring.
    Timmer CJ; Mulders TM
    Clin Pharmacokinet; 2000 Sep; 39(3):233-42. PubMed ID: 11020137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction with the pharmacokinetics of ethinylestradiol and progestogens contained in oral contraceptives.
    Jung-Hoffmann C; Kuhl H
    Contraception; 1989 Sep; 40(3):299-312. PubMed ID: 2527727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ethinylestradiol + norelgestromin: new preparation. Transdermal contraception: no tangible progress.
    Prescrire Int; 2004 Aug; 13(72):123-6. PubMed ID: 15532134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacodynamic and pharmacokinetic evaluation of coadministration of lacosamide and an oral contraceptive (levonorgestrel plus ethinylestradiol) in healthy female volunteers.
    Cawello W; Rosenkranz B; Schmid B; Wierich W
    Epilepsia; 2013 Mar; 54(3):530-6. PubMed ID: 23360419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.
    Jick S; Kaye JA; Li L; Jick H
    Contraception; 2007 Jul; 76(1):4-7. PubMed ID: 17586129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.